Research from Water Tower Research, Water Tower Research

Water Tower Research

Water Tower Research is a leading equity research firm that provides research on micro, small and mid cap companies.

Water Tower Research was founded by Wall Street veterans after witnessing a fundamental shift in the investment research industry with the result being a declining knowledge base among investors, a lack of awareness and a shrinking pool of fundamental research being conducted on companies across the small-cap and micro-cap spectrum. The same issues are now increasingly occurring in the mid-cap space. This sea change within the investment community is impacting not only the companies themselves but also current shareholders and potential investors. With significantly less active sell-side sponsorship by Wall Street, a substantial information gap has developed between companies and various constituents in the financial community. The net result is fewer channels for insight and information to flow between companies and investors.

Research from Water Tower Research

Equity Research Firm

Thematic (Sector/Industry)

United states Health care / Thematic (Sector/Industry)

<ul><li>The critical role of TREM2. Triggering receptor expressed on myeloid cells 2 (TREM2) is a protein that is primarily found on the surface of microglia.</li><li>Microglia are the primary immune cells of the central nervous system (CNS), which essentially act as the first and principal line of active immune defense in the CNS.</li><li>TREM2 helps the CNS immune system by enhancing microglia’s ability to clear toxic substances, abnormal proteins (such as amyloid beta), and cellular debris. I</li></ul>

The critical role of TREM2. Triggering receptor expressed on myeloid cells 2 (TREM2) is a protein that is primarily found on the surface of microglia.Microglia are the primary immune cells of the central nervous system (CNS), which essentially act as the first and principal line of active immune defense in the CNS.TREM2 helps the CNS immune system by enhancing microglia’s ability to clear toxic substances, abnormal proteins (such as amyloid beta), and cellular debris. I

Spotlight On Neurodegenerative Diseases Innovative Treatments: TREM2 Agonists